What volume of ceftriaxone (Rocephin) should be administered intramuscularly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Volume of Ceftriaxone (Rocephin) for Intramuscular Administration

The volume of ceftriaxone to administer IM depends on the dose prescribed and the concentration after reconstitution, which is determined by the amount of diluent added to the vial. After reconstitution, each 1 mL contains approximately 250 mg or 350 mg of ceftriaxone, depending on the diluent volume used 1.

Reconstitution Guidelines for IM Administration

The FDA-approved reconstitution instructions specify exact diluent volumes to achieve standard concentrations 1:

Standard Concentrations Available:

250 mg/mL concentration:

  • 250 mg vial: Add 0.9 mL diluent → withdraw entire contents
  • 500 mg vial: Add 1.8 mL diluent → withdraw entire contents
  • 1 gram vial: Add 3.6 mL diluent → withdraw entire contents
  • 2 gram vial: Add 7.2 mL diluent → withdraw entire contents

350 mg/mL concentration:

  • 500 mg vial: Add 1.0 mL diluent → withdraw entire contents
  • 1 gram vial: Add 2.1 mL diluent → withdraw entire contents
  • 2 gram vial: Add 4.2 mL diluent → withdraw entire contents

Calculating Volume to Administer

After reconstitution, withdraw the volume needed to deliver the prescribed dose based on the concentration you prepared.

Common Clinical Scenarios:

For uncomplicated gonorrhea (250 mg dose):

  • Using 250 mg/mL concentration: Administer 1 mL
  • Using 350 mg/mL concentration: Administer 0.7 mL

For pediatric otitis media (50 mg/kg, max 1 gram):

  • Example: 20 kg child needs 1000 mg
  • Using 250 mg/mL: Administer 4 mL
  • Using 350 mg/mL: Administer 2.9 mL

For adult infections (1-2 grams):

  • 1 gram using 250 mg/mL: Administer 4 mL
  • 2 grams using 250 mg/mL: Administer 8 mL

Critical Administration Points

Injection technique matters: Ceftriaxone must be injected deep into a large muscle mass with aspiration to avoid inadvertent intravascular injection 1.

Pain reduction: Some providers use 1% lidocaine as the diluent to reduce injection discomfort 2.

More dilute solutions are acceptable if needed for patient comfort or to distribute volume across multiple injection sites 1.

Age-Specific Dosing That Determines Volume

Neonates (≤28 days):

  • 50 mg/kg once daily for most infections
  • 100 mg/kg once daily for meningitis (not to exceed 4 grams)
  • Contraindicated in hyperbilirubinemic or premature neonates 1

Pediatric Patients:

  • 50-75 mg/kg once daily for skin/soft tissue infections (max 2 grams) 3, 1
  • 50 mg/kg single dose for otitis media (max 1 gram) 3, 1
  • 100 mg/kg once daily for meningitis (max 4 grams) 3, 1

Adults:

  • 250 mg single dose for uncomplicated gonorrhea 2, 4, 1
  • 1-2 grams once daily for most infections 1
  • Maximum 4 grams daily 1

Common Pitfalls to Avoid

Do not confuse vial size with dose. A 1 gram vial does not automatically mean you give the entire vial—calculate based on the patient's prescribed dose.

Do not use the 250 mg vial size for doses >250 mg as it's not cost-effective; use larger vials and withdraw the appropriate volume.

For large doses (>1 gram), consider dividing between two injection sites to improve tolerability, though this is not explicitly required by the label.

Ensure complete reconstitution by shaking the vial thoroughly before withdrawing the dose 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.